↓ Skip to main content

Signatures associated with homologous recombination deficiency and immune regulation to improve clinical outcomes in patients with lung adenocarcinoma

Overview of attention for article published in Frontiers in oncology, September 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter
4 X users

Readers on

mendeley
5 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Signatures associated with homologous recombination deficiency and immune regulation to improve clinical outcomes in patients with lung adenocarcinoma
Published in
Frontiers in oncology, September 2022
DOI 10.3389/fonc.2022.854999
Pubmed ID
Authors

Xueqian Shang, Kang Qi, Xiangzheng Liu, Qinghao Liu, Xining Zhang, Dongliang Wang, Weiming Huang

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 5 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 5 100%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 1 20%
Student > Doctoral Student 1 20%
Unknown 3 60%
Readers by discipline Count As %
Agricultural and Biological Sciences 1 20%
Unknown 4 80%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 October 2022.
All research outputs
#15,392,549
of 25,707,225 outputs
Outputs from Frontiers in oncology
#4,646
of 22,767 outputs
Outputs of similar age
#194,835
of 439,523 outputs
Outputs of similar age from Frontiers in oncology
#313
of 1,739 outputs
Altmetric has tracked 25,707,225 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,767 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 439,523 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 1,739 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.